Other comprehensive breast cancer screening strategies for BRCA1- and BRCA2-carrying women aged 60-74 were examined in the work of Phi et al. (2019), with their work revealing that only alternating between annual mammography and MRI for BRCA2 carriers and women with dense breasts is as cost-effective relative compared to annual mammography [12]. Here, BRCA2 is linked to breast cancer.